The Global Bioreactors Market Size accounted for USD 2.3 Billion in 2021 and is projected to occupy a market size of USD 6.5 Billion by 2030 growing at a CAGR of 12.4% from 2022 to 2030.
Bioreactor or fermenter is essential hardware required for bio processing. Bioreactors are explicitly developed systems or vessels that can bolster an organically live condition, as a particular encompassing is required for the cells to develop. The bioreactors by and large are accessible in the range from liters to cubic meters. Bioreactors utilized for expansive scale Cellion of therapeutics are typically made of stainless steel. Small glass bioreactors are regularly utilized for procedure advancement scale up and look into work in the biopharmaceutical segment. Single-use bioreactor, or dispensable bioreactor, has been discovering all the more wide assembling and research use. Bioreactors can execute as sustained clump, continuous mixed tank or bunch reactor frameworks.
Bioreactors Market Report Statistics
Global Bioreactors Market Dynamics
Bioreactors Market Report Coverage
|Bioreactors Market Size 2021||USD 2.3 Billion|
|Bioreactors Market Forecast 2030||USD 6.5 Billion|
|Bioreactors Market CAGR During 2022 - 2030||12.4%|
|Bioreactors Market Analysis Period||2018 - 2030|
|Bioreactors Market Base Year||2021|
|Bioreactors Market Forecast Data||2022 - 2030|
|Segments Covered||By Cell, By Molecule, By Product Type, By Usage, By End-Use, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Danaher Corporation, Merck Group, Thermo Fisher Scientific, Solaris Biotech Solutions, GE Healthcare, Sartorius, Eppendorf, Infors HT, Merck Millipore, Getinge, and others.
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Bioreactors Market Growth Factors
The main considerations driving the development of the worldwide bioreactors market are the ascent in acknowledgment of single-use innovations, expanding biologics, use hybrid technologies, for example, tempered steel and single-use, and the expanding demand for the single-use bioreactor in biopharmaceutical organizations. Different variables boosting the development of the worldwide market are low useful esteem combined with a base support and observing in respect with customary ones. Also, rising unending malady occurrence and developing exploration in the field of biopharmaceuticals will drive the worldwide bioreactor market size. Expanded focal point of biopharmaceutical organizations to create compelling treatment alternatives for the most vagrant illnesses should fuel industry development.
Bioreactors Market Segmentation
The global bioreactors Market is segmented based on cell, molecule, product type, usage, end-use, and geography.
Bioreactors Market By Cell
According to our bioreactor industry analysis, the mammalian cells sub-segment held over 76% of the market share in 2021 and is likely to continue this trend in the forthcoming years. The widespread use of mammalian cells in the development and commercialization of viral vaccines and therapeutic proteins, among other biopharmaceuticals, will drive demand for bioreactors.
Bioreactors Market By Molecule
According to our bioreactors market forecast, vaccines are expected to hold significant market share from 2022 to 2030. The rising prevalence of various chronic infectious diseases will fuel R&D activities for vaccine development, accelerating industry demand. Furthermore, the high prevalence of the COVID-19 virus has accelerated vaccine research and development efforts around the world, stimulating market growth.
Bioreactors Market By Product Type
Based on product type, the single-use bioreactors occupied maximum market share in 2021 and is likely to do so in the coming years. The significant market share in the segment is attributed to an increase in demand for biologic drugs, government initiatives for the development of the pharmaceutical sector, and advancement in R&D activities for vaccine production.
Bioreactors Market By Usage
By usage, developmental, preclinical & clinical sub-segment achieved a considerable market share and will continue to gather more market share in the coming future. On the other hand, commercial production sub-segment is anticipated to attain a quick growth during the forecast timeframe from 2022 to 2030.
Bioreactors Market By End-Use
The end-use segment is dominated by the biopharmaceutical manufacturers. The significant market share in the segment is attributed to an increase in demand for biologic drugs, government initiatives for the development of the pharmaceutical sector, and advancement in R&D activities for vaccine production. R&D organizations will grow with an impressive rate throughout the forecast period.
Bioreactors Market Regional Outlook
The Middle East & Africa
Bioreactors Market Regional Analysis
North America and Europe are thought to be the ruling regions in the worldwide bioreactor market because of the presence of major biopharmaceutical fabricating organizations. Asia Pacific is foreseen to develop essentially in the near future inferable from the enormous consumption conceded to the makers of biologics. Latin America is likewise expected to develop significantly in the worldwide market the same number of biopharmaceutical organizations are anticipating starting manufacturing units in this locale.
Bioreactors Market Players
The global Bioreactor market is characterized by the presence of experienced and established players. Some of the key players include Danaher Corporation, Merck Group, Thermo Fisher Scientific, Solaris Biotech Solutions, GE Healthcare, Sartorius, Eppendorf, Infors HT, Merck Millipore, Getinge, and others.
The market size of bioreactors market in 2021 was accounted to be USD 2.3 Billion.
The projected CAGR of bioreactors market during the analysis period of 2022 to 2030 is 12.4%.
The prominent players of the global bioreactors market include Danaher Corporation, Merck Group, Thermo Fisher Scientific, Solaris Biotech Solutions, GE Healthcare, Sartorius, Eppendorf, Infors HT, Merck Millipore, Getinge, and Others.
North America held the dominating bioreactors during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for bioreactors during the analysis period of 2022 to 2030.
Growing demand for monoclonal antibiotics, rising demand for single-use bioreactors, and technological advancement in bioreactors drives the growth of global bioreactors market.
Based on cell, mammalian cells segment is expected to hold the maximum share of the bioreactors market.